[1]刘 杰.尼可地尔对急性心肌梗死患者PCI术后心脏保护和预后的影响[J].医学信息,2023,36(03):144-147.[doi:10.3969/j.issn.1006-1959.2023.03.030]
　LIU Jie.Effect of Nicorandil on Cardiac Protection and Prognosis in Patients with Acute Myocardial Infarction After PCI[J].Journal of Medical Information,2023,36(03):144-147.[doi:10.3969/j.issn.1006-1959.2023.03.030]
点击复制

尼可地尔对急性心肌梗死患者PCI术后心脏保护和预后的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年03期
页码:
144-147
栏目:
药物与临床
出版日期:
2023-02-01

文章信息/Info

Title:
Effect of Nicorandil on Cardiac Protection and Prognosis in Patients with Acute Myocardial Infarction After PCI
文章编号:
1006-1959（2023）03-0144-04
作者:
刘 杰
（徐州医科大学附属医院心内科，江苏 徐州 221000）
Author(s):
LIU Jie
(Department of Cardiology,the Affiliated Hospital of Xuzhou Medical University,Xuzhou 221000,Jiangsu,China)
关键词:
尼可地尔; 急性心肌梗死; PCI术; 心脏保护
Keywords:
Nicorandil; Acute myocardial infarction; PCI; Cardiac protection
分类号:
R542.2+2
DOI:
10.3969/j.issn.1006-1959.2023.03.030
文献标志码:
A
摘要:
目的 研究尼可地尔对急性心肌梗死患者经皮冠状动脉介入治疗（PCI）术后心脏保护和预后的影响。方法 选取2018年1月-2020年1月在我院行PCI术的80例急性心肌梗死患者为研究对象，采用随机数字表法分为对照组和观察组，各40例。对照组采用常规抗血小板药物治疗，观察组在对照组基础上给予尼可地尔，比较两组心功能指标、血清脑钠肽（BNP）、肌酸激酶同工酶（CK-MB）、心肌肌钙蛋白Ⅰ（cTnⅠ）水平、梗死心肌灌注血流分级、并发症发生率以及临床不良反应发生情况。结果 两组术后1周LVEDD、LVESD、LVEF比较，差异无统计学意义（P＞0.05）；两组术后1个月LVEDD、LVESD均低于术后1周，LVEF均高于术后1周，且观察组LVEDD、LVESD低于对照组，LVEF高于对照组（P＜0.05）；两组术后1个月血清BNP、CK-MB、cTnⅠ水平均低于术前，且观察组低于对照组（P＜0.05）；观察组梗死心肌灌注血流2级、3级所占比例大于对照组，0级、1级所占比例小于对照组（P＜0.05）；观察组并发症发生率为7.50%，低于对照组的22.50%（P＜0.05）；观察组不良反应发生率为5.00%，与对照组的7.50%比较，差异无统计学意义（P＞0.05）。结论 尼可地尔对急性心肌梗死患者PCI术后心脏具有良好的保护作用，可促进心功能各指标，改善心肌血流分级，延缓心室重塑，进一步预防PCI术后并发症发生率，且不会增加不良反应发生率，有益于改善患者预后。
Abstract:
Objective To study the effect of nicorandil on cardiac protection and prognosis in patients with acute myocardial infarction after percutaneous coronary intervention (PCI).Methods A total of 80 patients with acute myocardial infarction who underwent PCI in our hospital from January 2018 to January 2020 were selected as the research objects. They were divided into control group and observation group by random number table method, with 40 cases in each group. The control group was treated with conventional antiplatelet drugs, and the observation group was given nicorandil on the basis of the control group. The cardiac function indexes, serum brain natriuretic peptide (BNP), creatine kinase isoenzyme (CK-MB), cardiac troponin Ⅰ(cTnⅠ) levels, infarcted myocardial perfusion blood flow grading, complication rate and clinical adverse reactions were compared between the two groups.Results There was no significant difference in LVEDD, LVESD and LVEF between the two groups at 1 week after operation (P>0.05). LVEDD and LVESD in the two groups at 1 month after operation were lower than those at 1 week after operation, LVEF was higher than that at 1 week after operation, and LVEDD and LVESD in the observation group were lower than those in the control group, LVEF was higher than that in the control group (P<0.05). The levels of serum BNP, CK-MB and cTnⅠ in the two groups at 1 month after operation were lower than those before operation, and those in the observation group were lower than those in the control group (P<0.05). The proportion of grade 2 and grade 3 of myocardial perfusion blood flow in the observation group was higher than that in the control group, and the proportion of grade 0 and grade 1 was lower than that in the control group (P<0.05). The incidence of complications in the observation group was 7.50%, which was lower than 22.50% in the control group (P<0.05). The incidence of adverse reactions in the observation group was 5.00%, compared with 7.50% in the control group, the difference was not statistically significant (P>0.05).Conclusion Nicorandil has a good protective effect on the heart after PCI in patients with acute myocardial infarction. It can promote the indexes of cardiac function, improve the classification of myocardial blood flow, delay ventricular remodeling, and further prevent the incidence of complications after PCI without increasing the incidence of adverse reactions, which is beneficial to improve the prognosis of patients.

参考文献/References:

[1]胡圣,张春阳,张成,等.尼可地尔静脉预注射对心肺复苏大鼠脑血流及神经功能的影响[J].山东医药,2017,57(38):34-37.[2]钟继明,黄学成,曾煜周.左西孟旦对急性ST段抬高型心肌梗死伴心力衰竭患者的血流动力学影响[J].广西医学,2017,39(9):1433-1436.[3]Lawson BD,Khan MZ,Cooke RH,et al.Safety of calcium channel blockers during radial cardiac catheterization in patients with acute myocardial infarction or systolic heart failure[J].J Invasive Cardiol,2019,31(4):107-110.[4]谢永生,邹兰.尼可地尔联合常规疗法在急性心力衰竭患者中治疗效果[J].齐齐哈尔医学院学报,2018,39(19):2290-2292.[5]王志清,陈美贤,刘东林,等.预防性冠状动脉内注射尼可地尔对急性段抬高型心肌梗死介入治疗后心肌血流灌注及预后的影响[J].中华心血管病杂志,2017,45(1):26-33.[6]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.非ST段抬高型急性冠状动脉综合征诊断和治疗指南(2016)[J].中华心血管病杂志,2017,45(5):359-376.[7]张新梅,刘香锟,李红梅,等.直接冠脉内注射替罗非班联合尼可地尔在急性心肌梗死患者急诊PCI中的疗效分析[J].新疆医科大学学报,2020,43(10):1332-1336.[8]韩孝宇,安建立,王文广,等.尼可地尔联合曲美他嗪对改善老年急性心肌梗死急性PCI术后心功能的作用[J].内科急危重症杂志,2018,24(6):467-471.[9]陈伟伟,高润霖,刘力生,等.《中国心血管病报告2017》概要[J].中国循环杂志,2018,33(1):1-8.[10]张京京,高扬,王成福,等.急性心肌梗死急诊经皮冠状动脉介入治疗后无复流现象的危险因素分析[J].贵州医药,2019,43(3):391-392.[11]皮淑芳,郑刚,刘迎午,等.尼可地尔对老年急性ST段抬高型心肌梗死患者介入术后心功能的影响[J].中华老年心脑血管病杂志,2018,20(9):923-926.[12]李玲,刘香格,李强,等.术前冠状动脉内注射尼可地尔对急性心肌梗死患者术后心肌血流灌注水平及心功能的影响[J].心脑血管病防治,2022,22(1):24-27.[13]杨颖,宋达,耿巍,等.围术期应用rhBNP对STEMI患者急诊PCI术中无复流-慢血现象、炎性因子和心功能的影响[J].河北医药,2018,40(2):215-218.[14]Berry C,Maznyczka AM,McCartney P.Failed myocardial reperfusion during primary PCI:an unmet therapeutic need[J].Euro Intervention,2019,14(16):1628-1630.[15]武晓玲,姜义卿,郑群,等.替罗非班联合尼可地尔对急诊PCI患者心功能和短期预后的影响[J].现代生物医学进展,2018,18(9):1750-1753.[16]黎文婷,姚朱华,庞志华,等.尼可地尔对急性非ST段抬高型心肌梗死PCI术中慢血流的疗效观察[J].天津医药,2017,45(11):1153-1157.[17]徐成胜.尼可地尔预注射对急性心肌梗死患者PCI术后心功能及临床预后的影响[J].心血管康复医学杂志,2020,29(4):445-448.[18]齐琪,陈涛,牛竞辉,等.冠状动脉靶血管内注射尼可地尔对急性ST段抬高型心肌梗死患者急诊经皮冠状动脉介入治疗术中无复流现象的预防效果研究[J].中国全科医学,2017,20(23):2832-2837,2847.[19]许嘉彬,王立波,陈伟达.急性ST段抬高型心肌梗死患者PCI术前应用尼可地尔对炎症反应和心肌损伤的影响[J].华南国防医学杂志,2018,32(28):8-11.[20]曾启祥.冠脉内注射尼可地尔对急性非ST段抬高型心肌梗死(NSTEMI)经皮冠状动脉介入治疗术(PCI)术中慢血流无复流的改善作用[J].中西医结合心血管病杂志,2019,7(2):75-79.

相似文献/References:

[1]郭建华.丹参川芎嗪联合阿托伐他汀钙治疗急性心肌梗死的疗效观察[J].医学信息,2018,31(01):145.[doi:10.3969/j.issn.1006-1959.2018.01.056]
　GUO Jian-hua.Effect of Salvia Miltiorrhiza Tetramethylpyrazine Combined with Atorvastatin Calcium in the Treatment of Acute Myocardial Infarction[J].Journal of Medical Information,2018,31(03):145.[doi:10.3969/j.issn.1006-1959.2018.01.056]
[2]余湘宁,赵献明.ECMO在危重症心脏疾病中的应用研究[J].医学信息,2018,31(04):38.[doi:10.3969/j.issn.1006-1959.2018.04.013]
　YU Xiang-ning,ZHAO Xian-ming.Study on the Application of ECMO in Critical Heart Disease[J].Journal of Medical Information,2018,31(03):38.[doi:10.3969/j.issn.1006-1959.2018.04.013]
[3]何 丽.应激性高血糖与急性心肌梗死的机制研究[J].医学信息,2022,35(10):74.[doi:10.3969/j.issn.1006-1959.2022.10.018]
　HE Li.Mechanism of Stress Hyperglycemia and Acute Myocardial Infarction[J].Journal of Medical Information,2022,35(03):74.[doi:10.3969/j.issn.1006-1959.2022.10.018]
[4]毛红岩,宁国贤.冠脉介入治疗对冠心病急性心肌梗死患者 心肌损伤及心室重塑的影响[J].医学信息,2018,31(12):102.[doi:10.3969/j.issn.1006-1959.2018.12.031]
　MAO Hong-yan,NING Guo-xian.Effects of Coronary Intervention on Myocardial Injury and Ventricular Remodeling in Patients with Coronary Heart Disease and Acute Myocardial Infarction[J].Journal of Medical Information,2018,31(03):102.[doi:10.3969/j.issn.1006-1959.2018.12.031]
[5]雷 锐,李 志.冠状动脉介入及替罗非班治疗老年急性心肌梗死并 心源性休克的疗效分析[J].医学信息,2018,31(14):150.[doi:10.3969/j.issn.1006-1959.2018.14.046]
　LEI Rui,LI Zhi.Effect of Coronary Intervention and Tirofiban on Elderly Patients with Acute Myocardial Infarction and Cardiogenic Shock[J].Journal of Medical Information,2018,31(03):150.[doi:10.3969/j.issn.1006-1959.2018.14.046]
[6]高 鹏,林文华,敬 锐,等.红细胞压积变化对急性ST段抬高型心肌梗死患者临床预后的影响[J].医学信息,2019,32(03):78.[doi:10.3969/j.issn.1006-1959.2019.03.024]
　GAO Peng,LIN Wen-hua,JING Rui,et al.Effect of Hematocrit Changes on Clinical Prognosis in Patients with Acute ST-segment Elevation Myocardial Infarction[J].Journal of Medical Information,2019,32(03):78.[doi:10.3969/j.issn.1006-1959.2019.03.024]
[7]高 珍,刘重斌,张菊英.氧疗对急性心肌梗死患者预后的影响[J].医学信息,2018,31(18):29.[doi:10.3969/j.issn.1006-1959.2018.18.011]
　GAO Zhen,LIU Chong-bin,ZHANG Ju-ying.Effect of Oxygenic Therapy on Prognosis of Patients with Acute Myocardial Infarction[J].Journal of Medical Information,2018,31(03):29.[doi:10.3969/j.issn.1006-1959.2018.18.011]
[8]韩 宇,朱丽丽,孙 婷,等.急性心肌梗死患者排便意愿的调查研究[J].医学信息,2018,31(20):111.[doi:10.3969/j.issn.1006-1959.2018.20.033]
　HAN Yu,ZHU Li-li,SUN Ting,et al.Investigation of Defecation Intention in Patients with Acute Myocardial Infarction[J].Journal of Medical Information,2018,31(03):111.[doi:10.3969/j.issn.1006-1959.2018.20.033]
[9]陈笑玲.急救护理流程再造在急性心肌梗死急诊介入治疗中的作用观察[J].医学信息,2018,31(23):168.[doi:10.3969/j.issn.1006-1959.2018.23.049]
　CHEN Xiao-ling.Effect of Emergency Nursing Process Reengineering on Emergency Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction[J].Journal of Medical Information,2018,31(03):168.[doi:10.3969/j.issn.1006-1959.2018.23.049]
[10]马洪俊,王玉平,刘 毅.主动脉内球囊反搏联合介入治疗急性心肌梗死伴心力衰竭的效果[J].医学信息,2022,35(13):136.[doi:10.3969/j.issn.1006-1959.2022.13.032]
　MA Hong-jun,WANG Yu-ping,LIU Yi.Effect of Intra-aortic Balloon Counterpulsation Combined with Interventional Therapy on Acute Myocardial Infarction Complicated with Heart Failure[J].Journal of Medical Information,2022,35(03):136.[doi:10.3969/j.issn.1006-1959.2022.13.032]

更新日期/Last Update: 1900-01-01